CL2011000073A1 - Uso de compuestos derivados de pirimidil-amino-benzamida; composicion farmaceutica ; y su uso en el tratamiento de fibrosis hepatica y fibrosis pulmonar. - Google Patents
Uso de compuestos derivados de pirimidil-amino-benzamida; composicion farmaceutica ; y su uso en el tratamiento de fibrosis hepatica y fibrosis pulmonar.Info
- Publication number
- CL2011000073A1 CL2011000073A1 CL2011000073A CL2011000073A CL2011000073A1 CL 2011000073 A1 CL2011000073 A1 CL 2011000073A1 CL 2011000073 A CL2011000073 A CL 2011000073A CL 2011000073 A CL2011000073 A CL 2011000073A CL 2011000073 A1 CL2011000073 A1 CL 2011000073A1
- Authority
- CL
- Chile
- Prior art keywords
- pyrimidyl
- amino
- treatment
- pharmaceutical composition
- fibrosis
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 208000005069 pulmonary fibrosis Diseases 0.000 title abstract 2
- 206010019668 Hepatic fibrosis Diseases 0.000 title 1
- 208000019425 cirrhosis of liver Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
- C07D239/12—Nitrogen atoms not forming part of a nitro radical
- C07D239/14—Nitrogen atoms not forming part of a nitro radical with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to said nitrogen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Uso de derivados de pirimidil-amino-benzamida; composición farmacéutica de dichos compuestos; combinación farmacéutica; y su uso en el tratamiento de fibrosis hepática y fibrosis pulmonar.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08160366 | 2008-07-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2011000073A1 true CL2011000073A1 (es) | 2011-07-15 |
Family
ID=39765085
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2011000073A CL2011000073A1 (es) | 2008-07-14 | 2011-01-13 | Uso de compuestos derivados de pirimidil-amino-benzamida; composicion farmaceutica ; y su uso en el tratamiento de fibrosis hepatica y fibrosis pulmonar. |
Country Status (17)
Country | Link |
---|---|
US (2) | US20110124670A1 (es) |
EP (1) | EP2300014A1 (es) |
JP (1) | JP2011528015A (es) |
KR (1) | KR20110051194A (es) |
CN (1) | CN102099039A (es) |
AU (1) | AU2009272814A1 (es) |
BR (1) | BRPI0915905A2 (es) |
CA (1) | CA2730225A1 (es) |
CL (1) | CL2011000073A1 (es) |
IL (1) | IL210290A0 (es) |
MA (1) | MA33166B1 (es) |
MX (1) | MX2011000511A (es) |
NZ (1) | NZ590177A (es) |
RU (1) | RU2011105059A (es) |
TW (1) | TW201006823A (es) |
WO (1) | WO2010007034A1 (es) |
ZA (1) | ZA201009153B (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20150098993A1 (en) * | 2011-07-28 | 2015-04-09 | Shireen Vali | Compositions, process of preparation of said compositions and method of treating inflammatory diseases |
JP6177768B2 (ja) * | 2012-04-24 | 2017-08-09 | 中外製薬株式会社 | ベンズアミド誘導体 |
BR112014026305A2 (pt) | 2012-04-24 | 2017-06-27 | Chugai Pharmaceutical Co Ltd | derivado de quinazolidinadiona |
CN103965195B (zh) * | 2013-02-01 | 2016-09-28 | 中国科学院广州生物医药与健康研究院 | 用于盘状结构域受体小分子抑制剂的化合物及其应用 |
CA2927830A1 (en) | 2013-10-23 | 2015-04-30 | Chugai Seiyaku Kabushiki Kaisha | Quinazolinone and isoquinolinone derivative |
CN106282033A (zh) * | 2016-08-15 | 2017-01-04 | 郑毅男 | 一株新青霉菌及其代谢产物安他拟酸a |
KR20210044589A (ko) * | 2019-10-15 | 2021-04-23 | 재단법인 한국파스퇴르연구소 | 2-메톡시에스트라디올 유도체 및 이들의 의약 용도 |
CN115010720B (zh) * | 2022-06-02 | 2023-08-11 | 中国科学院昆明植物研究所 | 中甸艾中倍半萜二聚体及其药物组合物与其制备方法和应用 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2426674A1 (en) * | 2000-10-25 | 2002-05-02 | Takeda Chemical Industries, Ltd. | Agent for preventing or treating portal hypertension |
DE60308337T2 (de) * | 2002-03-15 | 2007-09-20 | Novartis Ag | 4-(4-Methylpiperazin-1-ylmethyl)-N-(4-methyl-3-(4-pyrimidin-3-yl)pyrimidin-2-ylamino)phenylbenzamid zur Behandlung von Ang II vermitteltern Erkrankungen |
CN101035536A (zh) * | 2004-10-08 | 2007-09-12 | 诺瓦提斯公司 | 有机化合物的组合 |
WO2007022041A2 (en) * | 2005-08-11 | 2007-02-22 | Novartis Ag | Mutations and polymorphisms of hdac3 |
WO2007051862A1 (en) * | 2005-11-07 | 2007-05-10 | Novartis Ag | Combination of organic compounds |
US8093259B2 (en) * | 2006-05-25 | 2012-01-10 | Novartis Ag | 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-N-[5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl]-benzamide for treatment of melanoma |
KR20090055595A (ko) * | 2006-08-25 | 2009-06-02 | 노파르티스 아게 | 알도스테론 신타제 및/또는 11-베타-히드록실라제 및/또는 아로마타제에 의해 매개된 장애의 치료를 위한 융합 이미다졸 유도체 |
ES2409756T3 (es) * | 2006-12-04 | 2013-06-27 | Promedior, Inc. | Combinación de SAP y de enalapril para su uso en tratamiento de trastornos fibróticos o fibroproliferativos |
EP2094669A2 (en) * | 2006-12-18 | 2009-09-02 | Novartis AG | 1-substituted imidazole derivatives and their use as aldosterone synthase inhibitors |
EA200900812A1 (ru) * | 2006-12-18 | 2009-12-30 | Новартис Аг | Производные 4-имидазолил-1,2,3,4-тетрагидрохинолина и их применение в качестве ингибиторов альдостерон/11-бета-гидроксилазы |
-
2009
- 2009-07-13 TW TW098123638A patent/TW201006823A/zh unknown
- 2009-07-14 US US13/054,011 patent/US20110124670A1/en not_active Abandoned
- 2009-07-14 EP EP09797487A patent/EP2300014A1/en not_active Withdrawn
- 2009-07-14 BR BRPI0915905A patent/BRPI0915905A2/pt not_active IP Right Cessation
- 2009-07-14 RU RU2011105059/15A patent/RU2011105059A/ru unknown
- 2009-07-14 WO PCT/EP2009/058940 patent/WO2010007034A1/en active Application Filing
- 2009-07-14 KR KR1020117003226A patent/KR20110051194A/ko not_active Application Discontinuation
- 2009-07-14 CA CA2730225A patent/CA2730225A1/en not_active Abandoned
- 2009-07-14 MX MX2011000511A patent/MX2011000511A/es not_active Application Discontinuation
- 2009-07-14 CN CN2009801273499A patent/CN102099039A/zh active Pending
- 2009-07-14 NZ NZ590177A patent/NZ590177A/xx not_active IP Right Cessation
- 2009-07-14 AU AU2009272814A patent/AU2009272814A1/en not_active Abandoned
- 2009-07-14 JP JP2011517892A patent/JP2011528015A/ja active Pending
- 2009-07-14 MA MA33582A patent/MA33166B1/fr unknown
-
2010
- 2010-12-20 ZA ZA2010/09153A patent/ZA201009153B/en unknown
- 2010-12-27 IL IL210290A patent/IL210290A0/en unknown
-
2011
- 2011-01-13 CL CL2011000073A patent/CL2011000073A1/es unknown
-
2013
- 2013-06-06 US US13/911,127 patent/US20130267549A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2010007034A1 (en) | 2010-01-21 |
CN102099039A (zh) | 2011-06-15 |
US20130267549A1 (en) | 2013-10-10 |
KR20110051194A (ko) | 2011-05-17 |
BRPI0915905A2 (pt) | 2018-02-20 |
US20110124670A1 (en) | 2011-05-26 |
TW201006823A (en) | 2010-02-16 |
CA2730225A1 (en) | 2010-01-21 |
JP2011528015A (ja) | 2011-11-10 |
MA33166B1 (fr) | 2012-04-02 |
EP2300014A1 (en) | 2011-03-30 |
MX2011000511A (es) | 2011-02-24 |
IL210290A0 (en) | 2011-03-31 |
AU2009272814A1 (en) | 2010-01-21 |
NZ590177A (en) | 2012-12-21 |
ZA201009153B (en) | 2011-11-30 |
RU2011105059A (ru) | 2012-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2011000073A1 (es) | Uso de compuestos derivados de pirimidil-amino-benzamida; composicion farmaceutica ; y su uso en el tratamiento de fibrosis hepatica y fibrosis pulmonar. | |
CL2013001655A1 (es) | Compuestos bifenilicos sustituidos; composicion farmaceutica; y uso en el tratamiento o prevencion de fibrosis pulmonar, renal, hepatica o cutanea. | |
CL2011000846A1 (es) | Compuestos heterociclicos sustituidos; composicion farmaceutica; y su uso para el tratamiento de la hepatitis c. | |
BRPI0814769A2 (pt) | Composição sinérgica compreendendo substâncias aromatizantes e ácidos orgânicos e uso da mesma | |
BRPI0911333A2 (pt) | composições de limpeza que incorporam solventes verdes e métodos de uso. | |
EA200802008A1 (ru) | Фармацевтические композиции | |
BRPI0814593A2 (pt) | Composto, composição farmacêutica que o contém e uso do composto. | |
BRPI1005292A2 (pt) | composição de decapagem e uso da composição | |
BRPI0720124A2 (pt) | Composições farmacêuticas e seus métodos de uso. | |
CR10847A (es) | Compuesto heteromonociclico y uso del mismo | |
BR112012004335A2 (pt) | composto, composição farmacêutica, e, uso do composto. | |
BRPI0912717A2 (pt) | Composição farmacêutica, e, uso de 5-azacitidina | |
CL2009000200A1 (es) | Compuestos derivados de 2,7-naftiridinas-1-ona, mediadores de syk; composicion farmaceutica; y uso en el tratamiento de una enfermedad inflamatoria, respiratoria, proliferativa celular o autoinmune. | |
CL2008002295A1 (es) | Compuestos derivados de tiazolida sustituidos con alquilsulfonilos; composicion farmaceutica; y uso para el tratamiento de la hepatitis c. | |
BRPI0911688A2 (pt) | "compostos de pirimidina, composições e métodos de uso" | |
CL2011001333A1 (es) | Compuestos derivados de heterociclos nitrogenados sustituidos, inhibidores de ns5a; composicion farmaceutica; y su uso para el tratamiento de la hepatitis c. | |
CL2008003284A1 (es) | Compuestos derivados de 4-bencilamino-1-carboxiacil-piridina, inhibidores cetp; composicion farmaceutica que los comprende; combinacion farmaceutica; y uso en el tratamiento de enfermedades metabolicas, ateroesclerosis y cardiovasculares, entre otras. | |
CL2011000527A1 (es) | Compuestos derivados de benzofurano; composicion farmaceutica que los comprende;y su uso en el tratamiento de la hepatitis c. | |
ATE447568T1 (de) | Neue pyrinderivate | |
BRPI0820899A2 (pt) | Formulação cosmética, e, uso da composição | |
EA200901597A1 (ru) | Гербицидно активные бициклические 1,3-дионы | |
CR11772A (es) | Metodos y composicion liquidas de limpieza | |
CL2007001630A1 (es) | Compuestos derivados de pirrolidinamida; composicion farmaceutica; y uso para el tratamiento de la hepatitis c. | |
CL2007002207A1 (es) | Compuestos derivados de sulfonilaminas; composicion farmaceutica; y uso de los compuestos en el tratamiento del glaucoma. | |
CL2008001373A1 (es) | Compuestos derivados de fenilamino-benceno sustituidos; metodo de preparacion; composicion farmaceutica; kit farmceuticos; y uso de dichos compuestos en el tratamiento del cancer. |